Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Physiological Genomics
|
September 14, 2020
High-resolution analysis of differential gene expression during skeletal muscle atrophy and programmed cell death
Junko Tsuji, Travis Thomson, Elizabeth Chan, et al.
Histopathology
|
September 7, 2023
TSC2 inactivation, low mutation burden and high macrophage infiltration characterise hepatic angiomyolipomas
Krinio Giannikou, Katarzyna Klonowska, Junko Tsuji, et al.
The Journal of Molecular Diagnostics : JMD
|
March 15, 2024
Assay Validation of Cell-Free DNA Shallow Whole-Genome Sequencing to Determine Tumor Fraction in Advanced Cancers
Micah Rickles-Young, Gabriel Tinoco, Junko Tsuji, et al.
Briefings in Bioinformatics
|
October 17, 2025
Numbat-multiome: inferring copy number variations by combining RNA and chromatin accessibility information from single-cell data
Ruitong Li, Jean-Baptiste Alberge, Tina Keshavarzian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2023
Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group
Samuel Abbou, Kelly Klega, Junko Tsuji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2022
Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor-Positive Breast Cancer
Junko Tsuji, Tianyu Li, Albert Grinshpun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2021
Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations
Elio Adib, Katarzyna Klonowska, Krinio Giannikou, et al.
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors
Romanos Sklavenitis-Pistofidis, Elizabeth D Lightbody, Mairead Reidy, et al.
NPJ Precision Oncology
|
April 28, 2026
Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancer
David D Chen, Anat Zimmer, David D Yang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 3, 2024
Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone
Omar Nadeem, Michelle P Aranha, Robert Redd, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Physiological Genomics
|
September 14, 2020
High-resolution analysis of differential gene expression during skeletal muscle atrophy and programmed cell death
Junko Tsuji, Travis Thomson, Elizabeth Chan, et al.
Histopathology
|
September 7, 2023
TSC2 inactivation, low mutation burden and high macrophage infiltration characterise hepatic angiomyolipomas
Krinio Giannikou, Katarzyna Klonowska, Junko Tsuji, et al.
The Journal of Molecular Diagnostics : JMD
|
March 15, 2024
Assay Validation of Cell-Free DNA Shallow Whole-Genome Sequencing to Determine Tumor Fraction in Advanced Cancers
Micah Rickles-Young, Gabriel Tinoco, Junko Tsuji, et al.
Briefings in Bioinformatics
|
October 17, 2025
Numbat-multiome: inferring copy number variations by combining RNA and chromatin accessibility information from single-cell data
Ruitong Li, Jean-Baptiste Alberge, Tina Keshavarzian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2023
Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group
Samuel Abbou, Kelly Klega, Junko Tsuji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2022
Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor-Positive Breast Cancer
Junko Tsuji, Tianyu Li, Albert Grinshpun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2021
Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations
Elio Adib, Katarzyna Klonowska, Krinio Giannikou, et al.
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors
Romanos Sklavenitis-Pistofidis, Elizabeth D Lightbody, Mairead Reidy, et al.
NPJ Precision Oncology
|
April 28, 2026
Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancer
David D Chen, Anat Zimmer, David D Yang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 3, 2024
Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone
Omar Nadeem, Michelle P Aranha, Robert Redd, et al.
Page
of 3